Gupta J, Sharma G
Drug Deliv Transl Res. 2024; 15(2):455-482.
PMID: 39103593
DOI: 10.1007/s13346-024-01684-w.
Nguyen B, Baumfalk D, Lapierre-Nguyen S, Zhong R, Doerr V, Montalvo R
Exp Neurol. 2024; 378:114818.
PMID: 38782352
PMC: 11616575.
DOI: 10.1016/j.expneurol.2024.114818.
Li W, Cao J, Wang X, Zhang Y, Sun Q, Jiang Y
Front Pharmacol. 2021; 12:773834.
PMID: 34899332
PMC: 8652228.
DOI: 10.3389/fphar.2021.773834.
Noll N, Lal H, Merryman W
Am J Pathol. 2020; 190(8):1596-1608.
PMID: 32343958
PMC: 7416075.
DOI: 10.1016/j.ajpath.2020.04.006.
Mor Huertas A, Morton A, Hinkey J, Ichinoseki-Sekine N, Smuder A
Med Sci Sports Exerc. 2020; 52(7):1477-1484.
PMID: 31985575
PMC: 7901802.
DOI: 10.1249/MSS.0000000000002286.
IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?.
Sinha B, Mason R
J Drug Metab Toxicol. 2019; 6(3).
PMID: 31171989
PMC: 6548513.
DOI: 10.4172/2157-7609.1000186.
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.
Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P
Oncotarget. 2018; 9(18):14539-14551.
PMID: 29581862
PMC: 5865688.
DOI: 10.18632/oncotarget.24465.
Comparision of doxorubicin-induced cardiotoxicity in the ICR mice of different sources.
Kim S, Kim K, Kim J, Kwak J, Song H, Cho J
Lab Anim Res. 2017; 33(2):165-170.
PMID: 28747983
PMC: 5527143.
DOI: 10.5625/lar.2017.33.2.165.
Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.
Muramatsu Y, Matsui T, Deie M, Sato K
In Vivo. 2017; 31(1):61-68.
PMID: 28064222
PMC: 5354149.
DOI: 10.21873/invivo.11026.
Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots.
Wang C, Wu C, Zhou X, Han T, Xin X, Wu J
Sci Rep. 2013; 3:2852.
PMID: 24092333
PMC: 3790198.
DOI: 10.1038/srep02852.
Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.
Sayed-Ahmed M
Saudi Pharm J. 2013; 18(4):195-206.
PMID: 23960728
PMC: 3730973.
DOI: 10.1016/j.jsps.2010.07.008.
Mechanisms regulating resistance to inhibitors of topoisomerase II.
Ganapathi R, Ganapathi M
Front Pharmacol. 2013; 4:89.
PMID: 23914174
PMC: 3729981.
DOI: 10.3389/fphar.2013.00089.
The effect of combined exposure of 900 MHz radiofrequency fields and doxorubicin in HL-60 cells.
Jin Z, Zong C, Jiang B, Zhou Z, Tong J, Cao Y
PLoS One. 2012; 7(9):e46102.
PMID: 23029402
PMC: 3460948.
DOI: 10.1371/journal.pone.0046102.
RGS Proteins in Heart: Brakes on the Vagus.
Stewart A, Huang J, Fisher R
Front Physiol. 2012; 3:95.
PMID: 22685433
PMC: 3368389.
DOI: 10.3389/fphys.2012.00095.
Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism.
Huang J, Yang J, Maity B, Mayuzumi D, Fisher R
Cancer Res. 2011; 71(20):6310-9.
PMID: 21859827
PMC: 3196377.
DOI: 10.1158/0008-5472.CAN-10-3397.
Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy.
Khositseth A, Jirasakpisarn S, Pakakasama S, Choubtuym L, Wattanasirichaigoon D
Indian J Med Paediatr Oncol. 2011; 32(1):38-42.
PMID: 21731215
PMC: 3124989.
DOI: 10.4103/0971-5851.81889.
Phytochemical and cytotoxic investigations of Curcuma mangga rhizomes.
Malek S, Lee G, Hong S, Yaacob H, Abdul Wahab N, Weber J
Molecules. 2011; 16(6):4539-48.
PMID: 21629182
PMC: 6264423.
DOI: 10.3390/molecules16064539.
Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle.
Smuder A, Kavazis A, Min K, Powers S
J Appl Physiol (1985). 2011; 110(4):935-42.
PMID: 21310889
PMC: 3075128.
DOI: 10.1152/japplphysiol.00677.2010.
Cytotoxic components of Pereskia bleo (Kunth) DC. (Cactaceae) leaves.
Abdul Malek S, Shin S, Abdul Wahab N, Yaacob H
Molecules. 2009; 14(5):1713-24.
PMID: 19471192
PMC: 6254274.
DOI: 10.3390/molecules14051713.
Intracellular localisation studies of doxorubicin and Victoria Blue BO in EMT6-S and EMT6-R cells using confocal microscopy.
Burrow S, Phoenix D, Wainwright M, Tobin M
Cytotechnology. 2008; 39(1):15-25.
PMID: 19003300
PMC: 3449804.
DOI: 10.1023/A:1022435829894.
